MedPage Today (11/9, Hlavinka) reports, “The FDA gave marketing authorization to an Apple Watch app that detects and disrupts nightmares for adults with post-traumatic stress disorder (PTSD) or nightmare disorder, the agency announced” Nov. 6. The agency “granted NightWare breakthrough device designation and reviewed it through an expedited process intended for low to moderate risk devices.”
Medscape (11/9, Brooks, Subscription Publication) also covers the story.
Related Links:
— MedPage Today (requires login and subscription)